@article{16e8a0cf52b94deab51fb8d7ff787974,
title = "Percutaneous left atrial appendage occlusion in 2016",
author = "Apostolos Tzikas and Horst Sievert and Holmes, {David R.}",
note = "Funding Information: A. Tzikas is a consultant, proctor and has received speaker honoraria and research grants from St. Jude Medical. The Mayo Clinic and D. Holmes have licensed technology for LAAO to Boston Scientific. H. Sievert's institution has ownership interest in or has received consulting fees, travel expenses or study honoraria from the following companies: Abbott, Access Closure, AGA, Angiomed, Arstasis, Atritech, Atrium, Avinger, Bard, Boston Scientific, BridgePoint, Cardiac Dimensions, CardioKinetix, CardioMEMS, Coherex, Contego, CSI, EndoCross, EndoTex, Epitek, Evalve, ev3, FlowCardia, Gore, Guidant, Guided Delivery Systems, Inc., InSeal Medical, Lumen Biomedical, HLT, Kensey Nash, Kyoto Medical, Lifetech, Lutonix, Medinol, Medtronic, NDC, NMT, OAS, Occlutech, Osprey, Ovalis, Pathway, PendraCare, Percardia, pfm medical, Rox Medical, Sadra, SJM, Sorin, Spectranetics, SquareOne, Trireme, Trivascular, Velocimed, Veryan.",
year = "2016",
month = apr,
doi = "10.4244/EIJV11I14A307",
language = "English (US)",
volume = "11",
pages = "e1576--e1578",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "14",
}